跳到主要內容

Minogue Michael R 的 Form 4 申報

Abiomed Inc(ABMD),2021/8/6 申報

申報編號
0001179110-21-007996
申報時間
2021/8/6
交易日
2021/8/5
申報延遲
1 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 8 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $853.0 萬。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Minogue Michael RCIK 0001286370董事、高階主管(董事長、總裁、執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2021/8/5Common Stock $.01 par valueM行使選擇權取得+25,000$23.15+$578,750236,635直接
2021/8/5Common Stock $.01 par valueS賣出處分−14,887$340.27F7−$5,065,599.49221,748直接
2021/8/5Common Stock $.01 par valueS賣出處分−5,378$341.44F8−$1,836,264.32216,370直接
2021/8/5Common Stock $.01 par valueS賣出處分−1,335$342.48F9−$457,210.8215,035直接
2021/8/5Common Stock $.01 par valueS賣出處分−1,500$343.32F10−$514,980213,535直接
2021/8/5Common Stock $.01 par valueS賣出處分−500$345.33F11−$172,665213,035直接
2021/8/5Common Stock $.01 par valueS賣出處分−400$346.08F12−$138,432212,635直接
2021/8/5Common Stock $.01 par valueS賣出處分−1,000$344.43F13−$344,430211,635直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2021/8/5Common stockD交回公司處分−25,000$0.00$035,000直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F7

This price represents the sale price of the transactions on the reported date at $340.2661. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F8

This price represents the sale price of the transactions on the reported date at $341.4448. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F9

This price represents the sale price of the transactions on the reported date at $342.4849. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F10

This price represents the sale price of the transactions on the reported date at $3343.3223. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F11

This price represents the sale price of the transactions on the reported date at $345.3314. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F12

This price represents the sale price of the transactions on the reported date at $346.0750. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F13

This price represents the sale price of the transactions on the reported date at $344.4270. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)